Literature DB >> 1464868

Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort.

M Petri1, M Genovese.   

Abstract

OBJECTIVE: To determine the incidence of and risk factors for hospitalization in systemic lupus erythematosus (SLE).
METHOD: A prospective study of hospitalizations in 1989 and 1990 in the Hopkins Lupus Cohort was conducted.
RESULTS: Of 261 patients with SLE in the Hopkins Cohort, 147 (56.3%) were hospitalized in 1989 or 1990. The incidence of hospitalization was 0.69 admissions/person-year. The mean length of stay was 9.6 days +/- 12.7 (SD). Activity of SLE accounted for 35% of admissions. Risk factors for hospitalization for active lupus in 1990 included activity of SLE in 1989 (measured by either the highest physician's global assessment in 1989, p = 0.004, highest lupus activity index (LAI) score in 1989, p = 0.002, or highest systemic lupus erythematosus disease activity index score in 1989, p = 0.008), an average prednisone dose greater than 10 mg in 1989 (p = 0.002), and the presence of neurologic lupus in 1989 (p = 0.02). Medical admissions other than for active SLE accounted for an additional 27% of admissions; one-half of these admissions (47%) were for complications of SLE and/or its treatment, with coronary artery disease the most common (21% of medical admissions). Infections were responsible for 14% of admissions. The majority of infections were bacterial (90%). Risk factors for hospitalization for infection in 1990 included active SLE in 1989 (p = 0.03), average prednisone dose of greater than 10 mg in 1989 (p = 0.04), immunosuppressive drug use in 1989 (p = 0.003), neurologic SLE in 1989 (p = 0.02) and previous hospitalization in 1989 (p = 0.03).
CONCLUSION: Hospitalization is common in the Hopkins Lupus Cohort, with active SLE (35%), infection (14%, infection and/or active SLE; 11%, infection alone) and medical complications of SLE (13%) as the 3 most common causes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464868

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  43 in total

Review 1.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

Review 2.  Vaccine-preventable infections in Systemic Lupus Erythematosus.

Authors:  Giuseppe Murdaca; Andrea Orsi; Francesca Spanò; Valeria Faccio; Francesco Puppo; Paolo Durando; Giancarlo Icardi; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 3.  Why targeted therapies are necessary for systemic lupus erythematosus.

Authors:  L Durcan; M Petri
Journal:  Lupus       Date:  2016-09       Impact factor: 2.911

4.  Recurrent salmonella sepsis with different species in a systemic lupus erythematosus patient.

Authors:  L Green; S Vinker
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

5.  Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.

Authors:  Candace H Feldman; Francisco M Marty; Wolfgang C Winkelmayer; Hongshu Guan; Jessica M Franklin; Daniel H Solomon; Karen H Costenbader; Seoyoung C Kim
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

6.  Frequency, cost, and risk factors of readmissions among severe sepsis survivors.

Authors:  Andrew J Goodwin; David A Rice; Kit N Simpson; Dee W Ford
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

7.  Quality of life in patients with systemic lupus erythematosus (SLE) compared with related controls within a unique African American population.

Authors:  A Barnado; L Wheless; A K Meyer; G S Gilkeson; D L Kamen
Journal:  Lupus       Date:  2011-10-26       Impact factor: 2.911

8.  Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus.

Authors:  Debasis Biswas; Amrita Mathias; Rajeshwar Dayal; Amita Aggarwal; Ramnath Misra; Sita Naik
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

9.  Ethnic disparities among patients with systemic lupus erythematosus in South Carolina.

Authors:  Erica Anderson; Paul J Nietert; Diane L Kamen; Gary S Gilkeson
Journal:  J Rheumatol       Date:  2008-03-15       Impact factor: 4.666

10.  Predictors of major infections in systemic lupus erythematosus.

Authors:  Guillermo Ruiz-Irastorza; Nerea Olivares; Ioana Ruiz-Arruza; Agustin Martinez-Berriotxoa; Maria-Victoria Egurbide; Ciriaco Aguirre
Journal:  Arthritis Res Ther       Date:  2009-07-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.